In vitro activity of eravacycline against anaerobic bacteria isolated from clinically significant samples

Key Points

• Eravacycline demonstrates significant antimicrobial activity against anaerobic bacteria, providing a potential treatment option.
• The study identifies specific anaerobic pathogens sensitive to eravacycline, enhancing clinical treatment strategies.
• Assessment using in vitro methods revealed effective concentrations of eravacycline against key anaerobic species.
• The findings support the use of eravacycline in clinical settings, but further studies may be needed to confirm effectiveness.